Yuhang H. Li

8 East Street
Beijing, 100071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Effects of HPgV-1 Infections on Clinical Outcomes in Patients With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study.

Effects of HPgV-1 Infections on Clinical Outcomes in Patients With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study.

Journal: Clinical transplantation

Published: February 02, 2026

Base-resolution DNA methylome of human MDS hematopoietic stem cell reveals TET2-GFI1 epigenetic axis repressing MDS.

Base-resolution DNA methylome of human MDS hematopoietic stem cell reveals TET2-GFI1 epigenetic axis repressing MDS.

Journal: Immunity & inflammation

Published: January 12, 2026

Clinical observation of posttransplant lymphoproliferative disorder in a single center

Clinical observation of posttransplant lymphoproliferative disorder in a single center

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 05, 2026

The prognostic impact of myeloid co-mutation burden in TP53-mutated AML/MDS after allogeneic stem cell transplantation: a multicenter retrospective analysis.

The prognostic impact of myeloid co-mutation burden in TP53-mutated AML/MDS after allogeneic stem cell transplantation: a multicenter retrospective analysis.

Journal: Annals of hematology

Published: December 15, 2025

Mesenchymal stromal cells as add-on therapy to anti-CD25 antibodies for treating gastrointestinal-involved steroid-refractory acute graft-versus-host disease: a multicenter, single-arm, pivotal clinical trial.

Mesenchymal stromal cells as add-on therapy to anti-CD25 antibodies for treating gastrointestinal-involved steroid-refractory acute graft-versus-host disease: a multicenter, single-arm, pivotal clinical trial.

Journal: Stem cell research & therapy

Published: October 31, 2025

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial.

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial.

Journal: BMC medicine

Published: June 16, 2024

Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up.

Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up.

Journal: Frontiers in immunology

Published: May 22, 2024

Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis.

Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis.

Journal: Expert review of hematology

Published: December 22, 2023

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction.

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction.

Journal: Frontiers in genetics

Published: March 05, 2023

Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma.

Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma.

Journal: Journal of Cancer

Published: November 16, 2022

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction.

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction.

Journal: Frontiers in genetics

Published: November 08, 2022

Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review.

Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review.

Journal: Frontiers in immunology

Published: September 10, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026